This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  81R15021 YDB-D
 
  By: Crownover, Zerwas, Coleman, et al. H.B. No. 1672
 
  Substitute the following for H.B. No. 1672:
 
  By:  Gonzales C.S.H.B. No. 1672
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to newborn screening information.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter B, Chapter 33, Health and Safety
  Code, is amended by adding Sections 33.0111 and 33.0112 to read as
  follows:
         Sec. 33.0111.  DISCLOSURE. (a) The department shall develop
  a disclosure statement that discloses to the parent, managing
  conservator, or guardian of a newborn child subjected to screening
  tests under Section 33.011 that:
               (1)  the department or a laboratory established or
  approved by the department under Section 33.016 may retain for use
  by the department or laboratory genetic material used to conduct
  the newborn screening tests; and
               (2)  the parent, managing conservator, or guardian may
  limit the use of the genetic material by providing to the department
  in accordance with Section 33.0112 a written statement prohibiting
  the department or laboratory from retaining the genetic material.
         (b)  At the time a newborn child is subjected to screening
  tests under Section 33.011, the physician attending a newborn child
  or the person attending the delivery of a newborn child that is not
  attended by a physician shall provide the parent, managing
  conservator, or guardian of a newborn child a copy of the written
  disclosure statement developed by the department under this
  section.
         Sec. 33.0112.  STATEMENT PROHIBITING RETENTION OF GENETIC
  MATERIAL.  (a)  A parent, managing conservator, or guardian of a
  newborn child may file with the department a written statement
  prohibiting the department or a laboratory established or approved
  by the department from retaining any genetic material related to
  the newborn screening tests conducted under this subchapter.
         (b)  Not later than the 60th day after the department
  receives the written statement, the department or laboratory shall
  destroy the genetic material used in the screening tests.
         SECTION 2.  Subchapter B, Chapter 33, Health and Safety
  Code, is amended by adding Section 33.017 to read as follows:
         Sec. 33.017.  CONFIDENTIALITY.  (a)  Reports, records, and
  information obtained or developed by the department under this
  chapter are confidential and are not subject to disclosure under
  Chapter 552, Government Code, are not subject to subpoena, and may
  not otherwise be released or made public except as provided by this
  section.
         (b)  Notwithstanding other law, reports, records, and
  information obtained or developed by the department under this
  chapter may be disclosed:
               (1)  for purposes of diagnosis or follow-up authorized
  under Section 33.014;
               (2)  with the consent of each identified individual or
  an individual authorized to consent on behalf of an identified
  child;
               (3)  as authorized by court order;
               (4)  to a medical examiner authorized to conduct an
  autopsy on a child or an inquest on the death of a child; or
               (5)  to public health programs of the department for
  public health research purposes provided that the disclosure is
  approved by an institutional review board or privacy board of the
  department as authorized by the federal privacy requirements
  adopted under the Health Insurance Portability and Accountability
  Act of 1996 (Pub. L. No. 104-191) contained in 45 C.F.R. Part 160
  and 45 C.F.R. Part 164, Subparts A and E.
         (c)  Notwithstanding other law, reports, records, and
  information that do not identify a child or the family of a child
  may be released without consent if the disclosure is for:
               (1)  statistical purposes;
               (2)  purposes related to obtaining or maintaining
  certification, approval, or quality assurance for the department's
  laboratory or a public or private laboratory to perform newborn
  screening tests;
               (3)  purposes relating to review, quality assurance, or
  improvement of the department's newborn screening under this
  subchapter or the department's newborn screening program services
  under Subchapter C;
               (4)  research purposes, provided that the disclosure is
  approved by an institutional review board or privacy board of the
  department; or
               (5)  quality assurance related to equipment and
  supplies, provided that:
                     (A)  the assessment is performed by a person who
  is not a laboratory;
                     (B)  only newborn screening specimens are
  disclosed; and
                     (C)  the disclosure is approved by an
  institutional review board or privacy board of the department.
         (d)  A state officer or employee, a department contractor, or
  a department contractor's employee, officer, director, or
  subcontractor may not be examined in a civil, criminal, special, or
  other judicial or administrative proceeding as to the existence or
  contents of records, reports, or information made confidential by
  this section unless disclosure is authorized by this section.
         SECTION 3.  As soon as practicable after the effective date
  of this Act, the Department of State Health Services shall develop
  the disclosure statement required by Section 33.0111, Health and
  Safety Code, as added by this Act.  The department may modify an
  existing form for use for purposes of that section.
         SECTION 4.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2009.